Lumiquin Cream

Composition:

Each gram of cream contains:

• Hydroquinone 40mg
• Tretinoin 0.5mg
• Fluocinolone acetonide 0.1mg

Indication:

• Indicated for short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
• LUMIQUIN cream contains corticosteroids, retinoids, and the depigmenting agent is not indicated for the maintenance treatment of melasma.
• The safety and efficacy of LUMIQUIN cream in the treatment of hyperpigmentation conditions other than melasma of the face have not been studied.

How to use:

• Apply a thin film of the cream to the areas of melasma once daily at night, at least 30 minutes before bedtime, after cleansing the face.
• Kept away from the eyes, nose, or angle of the mouth.
• Usage is not recommended for more than 8 weeks, or as directed by your medical physician. Do not use occlusive dressing.
• If local irritation persists or becomes severe, application of the medication should be discontinued, and contact your physician.
• To keep from dry conditions, patients may use moisturizers and/or cosmetics every morning after cleansing the face.
• Avoid sun exposure and use sunscreen with SPF 30 or greater to protect the medicated area from sun exposure.
• Therapeutics effect may be observed as early as 4 weeks. If no change occurs, the use of the medication should be discontinued.

Attention:

• Store below 30°C, tightly closed, and protect from light.
• For external use only.

Packaging:

Tube, 15g

Produced by:

PT. Genero Pharmaceuticals
Bekasi, Indonesia